CD5+ B cells in Graves' disease: Correlation with disease activity

Hormone and Metabolic Research

Volumn 28, Issue 6, 1996, Pages 280-285

  Corrales, J J ^b,c   Orfao, A ^a   Lopez A ^a   Mories, M T ^b   Miralles, J M ^b   Ciudad, J ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

anti thyrotropin receptor antibodies; CD5+ B cells; Graves' disease; hyperthyroidism; interleukin 2; interleukin 6

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; LIOTHYRONINE; THIAMAZOLE; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029886818     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979792     Document Type: Article

References (30)

1. Alberolla-lla, J., L. Places, D. A. Cantrell, J. Vives, F. Lozano: Intracellular events involved in CD5- induced human T cell activation and proliferation. J. Immunol. 148: 1287-1293 (1992)
2. Becker, H., C. Weber, S. Storch, K. Federlin: Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. Clin. Immunol. Immunopathol. 56: 219-225 (1990)
3. Casali, P., S. E. Burastero, M. Nakamura, G. Inghirami, A. L. Notkins: Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 236: 77-80 (1987)
4. Casali, P., S. E. Burastero, J. E. Balow, A. L. Notkins: High affinity antibodies to ssDNA are produced by CD5- B cells in systemic lupus erythematosus patients. J. Immunol. 143: 3476-3483 (1989)
5. Cho, B. Y., M. H. Shong, K. H. Yi, H. K. Lee, C. S. Koh, H. K. Min: Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease. Clin. Endocrinol. 36: 585-590 (1992)
6. Corrales, J. J., J. M. Tabernero, J. M. Miralles, M. T. Hernández: Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiter. Klin. Wochenschr. 69: 19-24 (1991)
7. Corrales, J. J., A. Orfao, J. M. Miralles, J. San Miguel: The relationship between hyperthyroidism and the distribution of peripheral blood T, NK and B-lymphocytes in multinodular goiter. Horm. Metab. Res. 26: 104-108 (1994)
8. Dixon, W. I.: BMDP statistical software. Berkeley: University of California Press (1983)
9. Dower, S. K., C. A. Smith, L. S. Park: Human cytokine receptors. J. Clin. Immunol. 10: 289-299 (1990)
10. Greenspan, F. S.: The thyroid gland. In: Basic and clinical endocrinology; Greenspan and Baxter (eds.) Prentice-Hall International Inc. (1994), pp. 160-226
11. Hardy, R. R., K. Hayakawa, M. Shimizu, K. Yamasaki, T. Kishimoto: Rheumathoid factor secretion from human Leu-1+ B cells. Science 236: 81-83 (1987)
12. Hirano, T.: Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopathol. 62: S60-S65 (1992)
13. Iwatani, Y., M. Iitaka, V. V. Row, R. Volpé: Induction of thyroid autoantibody production: Synergistic effect of B cell mitogen combined with T cell mitogen. J. Clin. Endocrinol. Metab. 65: 853-861 (1987)
14. Iwatani, Y., N. Amino, T. Kaneda, K. Ichihara, H. Tamaki, J. Tachi, F. Matzuzuka, S. Fukata, K. Kuma, K. Miyai: Marked increase of CD5+ B cells in hyperthyroid Graves' disease. Clin. Exp. Immunol. 78: 196-200 (1989)
15. Jones, T. H.: Interleukin-6, an endocrine cytokine. Clin. Endocrinol. 40: 703-713 (1994)
16. Kasaian, M. T., H. Ikematsu, P. Casali: Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J. Immunol. 148: 2690-2702 (1992)
17. Kipps, T. J., J. H. Vaughan: Genetic influence on the levels of circulating CD5 B lymphocytes. J. Immunol. 139: 1060-1064 (1987)
18. Kishimoto, T., S. Akira, T. Taga: Interleukin-6 and its receptor: a paradigm for cytokines. Science 258: 593-597 (1992)
19. Lipsky, P. E.: The control of antibody production by immunomodulatory molecules. Arthritis Rheum. 32: 1345-1356 (1989)
20. Mories, M. T., J. M. Miralles, A. Reglero, S. Felipe, J. J. Corroies, L. C. García Diez: A study of thyroglobulin and peroxidase activity in the thyroid tissue of patients with non-endemic non-toxic nodular goiter. Clin. Sci. 80: 301-307 (1991)
21. Muñoz, A., T. Gallart, O. Viñas, R. Gomis: Increased CD5- positive B lymphocytes in type I diabetes. Clin. Exp. Immunol. 83: 304-308 (1991)
22. Muraguchi, A., T. Hirano, B. Tang, T. Matsuda, Y. Horii, K. Nakajima, T. Kishimoto: The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167: 332-343 (1988)
23. Nagafuchi, H., N. Suzuki, Y. Mizushima, T. Sakane: Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151: 6525-6534 (1993)
24. Schaftner, A.: Lymphokines in autoimmunity. A critical review. Clin. Immunol. Immunopathol. 70: 177-189 (1994)
25. Smith, K. A.: Interleukin-2: Inception, impact, and implications. Science 240: 1169-1176 (1988)
26. Solvason, N., J. Kearney: The human fetal omentum: A site of B cell generation. J. Exp. Med. 175: 397-404 (1992)
27. Tötterman, T. H., F. A. Karlsson, M. Bengtsson, I. Mendel-Hartvig: Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. New Engl. J. Med. 316: 15-22 (1987)
28. Tsudo, M., T. Uchiyama, H. Uchino: Expression of Tac antigen on activated normal human B cells. J. Exp. Med. 160: 612-617 (1984)
29. Waldmann, T. A., C. K. Goldman, R. J. Robb, J. M. Depper, W. J. Leonard, S. O. Sharrow, K. F. Bongiovanni, S. J. Korsmeyer, W. C. Greene: Expression of interleukin 2 receptors on activated human B cells. J. Exp. Med. 160: 1450-1466 (1984)
30. Werner-Favre, C., T. L. Vischer, D. Wohlwend, R. H. Zubler: Cell surface antigen CD5 is a marker for activated human B cells. Eur. J. Immunol. 19: 1209-1213 (1989)